Most Osteomalacia-associated Mesenchymal Tumors Are a Single Histopathologic Entity: An Analysis of 32 Cases and a Comprehensive Review of the Literature

American Journal of Surgical Pathology

Volumn 28, Issue 1, 2004, Pages 1-30

  Folpe, Andrew L ^a,q   Fanburg Smith, Julie C ^b   Billings, Steven D ^c   Bisceglia, Michele ^d   Bertoni, Franco ^e   Cho, Justin Y ^f   Econs, Michael J ^c   Inwards, Carrie Y ^g   Jan De Beur, Suzanne M ^f   Mentzel, Thomas ^h   Montgomery, Elizabeth ^f   Michal, Michal ⁱ   Miettinen, Markku ^b   Mills, Stacey E ^p   Reith, John D ^j   O'Connell, John X ^k   Rosenberg, Andrew E ^l   Rubin, Brian P ^m   Sweet, Donald E ^b   Vinh, Tuyethoa N ^b   Wold, Lester E ^g   Wehrli, Brett M ⁿ   White, Kenneth E ^c   Zaino, Richard J ^o   Weiss, Sharon W ^a   more..

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^e UNIVERSITY OF BOLOGNA   (Italy)

^f JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g MAYO CLINIC   (United States)

^h Dermatopathologische Gemeinschaftspraxis   (Germany)

ⁱ CHARLES UNIVERSITY   (Czech Republic)

^j UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^k SURREY MEMORIAL HOSPITAL   (Canada)

^l MASSACHUSETTS GENERAL HOSPITAL   (United States)

^m UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

ⁿ LONDON HEALTH SCIENCES CENTRE   (Canada)

^o PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^p UNIVERSITY OF VIRGINIA MEDICAL CENTER   (United States)

^q EMORY UNIVERSITY HOSPITAL   (United States)

more..

Author keywords

Hemangiopericytoma; Immunohistochemistry; Mesenchymal tumors; Oncogenic osteomalacia; Phosphaturia; Sarcoma

Indexed keywords

ACTIN; ANTINEOPLASTIC AGENT; CD34 ANTIGEN; CYTOKERATIN; DESMIN; FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 23; PHOSPHATE; PROTEIN S 100; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ANAMNESIS; BLEEDING; BONE; CANCER SURVIVAL; CLINICAL ARTICLE; CYTOLOGY; DATA ANALYSIS; DIAGNOSTIC ERROR; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; EXTRACELLULAR MATRIX; FEMALE; FOLLOW UP; GIANT CELL TUMOR; HEMANGIOPERICYTOMA; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY TUBULE; LITERATURE; LUNG METASTASIS; MALE; MESENCHYMOMA; MIXED CONNECTIVE TISSUE DISEASE; OSSIFICATION; OSTEOCLAST; OSTEOID; OSTEOMALACIA; OSTEOSARCOMA; PARANEOPLASTIC SYNDROME; PHOSPHATURIA; PHOSPHATURIC MESENCHYMAL TUMOR; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SCHOOL CHILD; SOFT TISSUE; SPINDLE CELL; TUMOR LOCALIZATION; TUMOR VOLUME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BONE NEOPLASMS; CHILD; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MESENCHYMOMA; MIDDLE AGED; OSTEOMALACIA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SOFT TISSUE NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 9144231813     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000478-200401000-00001     Document Type: Review

References (112)

1. ADHR Consortium. Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23. Nat Genet. 2000;26:345-348.
2. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 29-2001. A 14-year-old with abnormal bones and a sacral mass. N Engl J Med. 2001;345:903-908.
3. Osteomalacia in a 61-year-old man. Am J Med. 1987;83:509-518.
4. Agus ZS. Oncogenic hypophosphatemic osteomalacia. Kidney Int. 1983;24:113-123.
5. Aschinberg LC, Solomon LM, Zeis PM, et al. Vitamin D-resistant rickets associated with epidermal nevus syndrome: demonstration of a phosphaturic substance in the dermal lesions. J Pediatr. 1977;91:56-60.
6. Asnes RS, Berdon WE, Bassett CA. Hypophosphatemic rickets in an adolescent cured by excision of a nonossifying fibroma. Clin Pediatr (Phila). 1981;20:646-648.
7. Avila NA, Skarulis M, Rubino DM, et al. Oncogenic osteomalacia: lesion detection by MR skeletal survey. AJR Am J Roentgenol. 1996;167:343-345.
8. Baronofsky SI, Kalbhen CL, Demos TC, et al. Oncogenic osteomalacia secondary to a hemangiopericytoma of the hip: case report. Can Assoc Radiol J. 1999;50:26-28.
9. Ben-Baruch D, Ziv Y, Sandbank J, et al. Oncogenic osteomalacia induced by schwannoma in a patient with neurofibromatosis. Eur J Surg Oncol. 1994;20:57-61.
10. Boriani S, Campanacci M. Osteoblastoma associated with osteomalacia (presentation of a case and review of the literature). Ital J Orthop Traumatol. 1978;4:379-382.
11. Bowe AE, Finnegan R, Jan de Beur SM, et al. FGF-23 inhibits renal tubular phosphate transport and is a PHEX substrate. Biochem Biophys Res Commun. 2001;284:977-981.
12. Cai Q, Hodgson SF, Kao PC, et al. Brief report: inhibition of renal phosphate transport by a tumor product in a patient with oncogenic osteomalacia [comment]. N Engl J Med. 1994;330:1645-1649.
13. Castleman B, McNeeley BU. Case records of the Massachusetts General Hospital: case 38-1965. N EngI J Med. 1965;273:494-504.
14. Cehreli C, Alakavuklar MN, Cavdar C, et al. Oncogenous osteomalacia: report of a case. Acta Oncol. 1994;33:975-976.
15. Cheng CL, Ma J, Wu PC, et al. Osteomalacia secondary to osteosarcoma: a case report. J Bone Joint Surg Am. 1989;71:288-292.
16. Clunie GP, Fox PE, Stamp TC. Four cases of acquired hypophosphataemic ('oncogenic') osteomalacia: problems of diagnosis, treatment and long-term management. Rheumatology (Oxford). 2000;39:1415-1421.
17. Coindre JM, Mage P, Bui BN, et al. Metastases osteocondensantes prostatiques et osteomalacie: interet de l'etude histomorphometrique. Resultats preliminaires. Presse Med. 1985;14:1823-1827.
18. Cotton GE. Oncogenic osteomalacia. N Engl J Med. 1994;331:1023.
19. Cotton GE, Van Puffelen P. Hypophosphatemic osteomalacia secondary to neoplasia. J Bone Joint Surg Am. 1986;68:129-133.
20. Daniels RA, Weisenfeld I. Tumorous phosphaturic osteomalacia: report of a case associated with multiple hemangiomas of bone. Am J Med. 1979;67:155-159.
21. David K, Revesz T, Kratimenos G, et al. Oncogenic osteomalacia associated with a meningeal phosphaturic mesenchymal tumor: case report. J Neurosurg. 1996;84:288-292.
22. Drezner MK, Feinglos MN. Osteomalacia due to 1alpha,25-dihydroxy-cholecalciferol deficiency: association with a giant cell tumor of bone. J Clin Invest. 1977;60:1046-1053.
23. Econs MJ, Drezner MK. Tumor-induced osteomalacia: unveiling a new hormone. N Engl J Med. 1994;330:1679-1681.
24. Edmister KA, Sundaram M. Oncogenic osteomalacia. Semin Musculoskelet Radiol. 2002;6:191-196.
25. Evans DJ, Azzopardi JG. Distinctive tumours of bone and soft tissue causing acquired vitamin-D-resistant osteomalacia. Lancet. 1972;1:353-354.
26. Firth RG, Grant CS, Riggs BL. Development of hypercalcemic hyperparathyroidism after long-term phosphate supplementation in hypophosphatemic osteomalacia: report of two cases. Am J Med. 1985;78:669-673.
27. Fletcher CD. Distinctive soft tissue tumors of the head and neck. Mod Pathol. 2002;15:324-330.
28. Francois S, Lefort G, Poli-Merol ML, et al. Vitamin-resistant rickets cured by removal of a bone tumor: review of the literature. Rev Chir Orthop Reparatrice Appar Mot. 1997;83:387-392.
29. Fukumoto S, Takeuchi Y, Nagano A, et al. Diagnostic utility of magnetic resonance imaging skeletal survey in a patient with oncogenic osteomalacia. Bone. 1999;25:375-377.
30. Fukumoto Y, Tarui S, Tsukiyama K, et al. Tumor-induced vitamin D-resistant hypophosphatemic osteomalacia associated with proximal renal tubular dysfunction and 1,25-dihydroxyvitamin D deficiency. J Clin Endocrinol Metab. 1979;49:873-878.
31. Garcia CA, Spencer RP. Bone and In-111 octreotide imaging in oncogenic osteomalacia: a case report. Clin Nucl Med. 2002;27:582-583.
32. Gascon A, Cobeta-Garcia JC, Iglesias E, et al. Oncogenic osteomalacia in a patient with a fibrocystic nodule of the breast. Nephrol Dial Transplant. 1999;14:1561-1563.
33. Gitelis S, Ryan WG, Rosenberg AG, et al. Adult-onset hypophosphatemic osteomalacia secondary to neoplasm: a case report and review of the pathophysiology. J Bone Joint Surg Am. 1986;68:134-138.
34. Gonzalez-Compta X, Manos-Pujol M, Foglia-Fernandez M, et al. Oncogenic osteomalacia: case report and review of head and neck associated tumours. J Laryngol Otol. 1998;112:389-392.
35. Granados R, Martin-Hita A, Rodriguez-Barbero JM, et al. Fine-needle aspiration cytology of chondroblastoma of soft parts: case report and differential diagnosis with other soft tissue tumors. Diagn Cytopathol. 2003;28:76-81.
36. Harvey JN, Gray C, Belchetz PE. Oncogenous osteomalacia and malignancy. Clin Endocrinol (Oxf). 1992;37:379-382.
37. Hasegawa T, Shimoda T, Yokoyama R, et al. Intracortical osteoblastic osteosarcoma with oncogenic rickets. Skeletal Radiol. 1999;28:41-45.
38. Haviv YS, Silver J. Late onset oncogenic osteomalacia-associated with neurofibromatosis type 11. Clin Nephrol. 2000;54:429-430.
39. Huang QL, Feig DS, Blackstein ME. Development of tertiary hyperparathyroidism after phosphate supplementation in oncogenic osteomalacia. J Endocrinol Invest. 2000;23:263-267.
40. Jan De Beur SM, Finnegan RB, Vassiliadis J, et al. et al. Tumors associated with oncogenic osteomalacia express genes important in bone and mineral metabolism. J Bone Miner Res. 2002;17:1102-1110.
41. Jan de Beur SM, Streeten EA, Civelek AC, et al. Localisation of mesenchymal tumours by somatostatin receptor imaging. Lancet. 2002;359:761-763.
42. John MR, Wickert H, Zaar K, et al. A case of neuroendocrine oncogenic osteomalacia associated with a PHEX and fibroblast growth factor-23 expressing sinusoidal malignant schwannoma. Bone. 2001;29:393-402.
43. Kaplan PA, Dussault RG, Buchanan PK, et al. Musculoskeletal case of the day: oncogenic osteomalacia. AJR Am J Roentgenol. 1996;167:253,256-257.
44. Kawai Y, Morimoto S, Sakaguchi K, et al. Oncogenic osteomalacia secondary to nasal tumor with decreased urinary excretion of cAMP. J Bone Miner Metab. 2001;19:61-64.
45. Leicht E, Kramann B, Seitz G, et al. Oncogenic osteomalacia: imaging studies. Bildgebung. 1993;60:13-17.
46. Lever EG, Pettingale KW. Albright's syndrome associated with a soft-tissue myxoma and hypophosphataemic osteomalacia: report of a case and review of the literature. J Bone Joint Surg Br. 1983;65:621-626.
47. Linovitz RJ, Resnick D, Keissling P, et al. Tumor-induced osteomalacia and rickets: a surgically curable syndrome. Report of two cases. J Bone Joint Surg Am. 1976;58:419-423.
48. Linsey M, Smith W, Yamauchi H, et al. Nasopharyngeal angiofibroma presenting as adult osteomalacia: case report and review of the literature. Laryngoscope. 1983;93:1328-1331.
49. Lustman F, Parmentier R, Dustin P. Oncogenic osteomalacia and renal adenomatoid dysplasia. Ann Intern Ifed. 1985;102:869-870.
50. McCance RA. Osteomalacia with Looser's nodes (Milkman's Syndrome) due to a raised resistance to Vitamin D acquired about the age of 15 years. Q J Med. 1947;16:33-46.
51. McClure J, Smith PS. Oncogenic osteomalacia. J Clin Pathol. 1987;40:446-453.
52. McGuire MH, Merenda JT, Etzkorn JR, et al. Oncogenic osteomalacia: a case report. Clin Orthop. 1989;244:305-308.
53. McMurtry CT, Godschalk M, Malluche HH, et al. Oncogenic osteomalacia associated with metastatic prostate carcinoma: case report and review of the literature. J Am Geriatr Soc. 1993;41:983-985.
54. Moran M, Paul A. Octreotide scanning in the detection of a mesenchymal tumour in the pubic symphysis causing hypophosphataemic osteomalacia. Int Orthop. 2002;26:61-62.
55. Nakahama H, Nakanishi T, Uno H, et al. Prostate cancer-induced oncogenic hypophosphatemic osteomalacia. Urol Int. 1995;55:38-40.
56. Nelson AE, Mason RS, Robinson BG, et al. Diagnosis of a patient with oncogenic osteomalacia using a phosphate uptake bioassay of serum and magnetic resonance imaging. Eur J Endocrinol. 2001;145:469-476.
57. Nguyen BD, Wang EA. Indium-111 pentetreotide scintigraphy of mesenchymal tumor with oncogenic osteomalacia. Clin Nucl Med. 1999;24:130-131.
58. Nitzan DW, Horowitz AT, Darmon D, et al. Oncogenous osteomalacia: a case study. Bone Miner. 1989;6:191-197.
59. Nomura G, Koshino Y, Morimoto H, et al. Vitamin D resistant hypophosphatemic osteomalacia associated with osteosarcoma of the mandible: report of a case. Jpn J Med. 1982;21:35-39.
60. Nuovo MA, Dorfman HD, Sun CC, et al. Tumor-induced osteomalacia and rickets. Am J Surg Pathol. 1989;13:588-599.
61. Oba K, Takei A, Natori S, et al. Tumor-induced osteomalacia in a patient with a phosphaturic mesenchymal tumor revealing feature of an ossifying fasciitis of the left abdominal wall. Nippon Naika Gakkai Zasshi. 2002;91:1870-1872.
62. Ogose A, Hotta T, Emura I, et al. Recurrent malignant variant of phosphaturic mesenchymal tumor with oncogenic osteomalacia. Skeletal Radiol. 2001;30:99-103.
63. Ohashi K, Ohnishi T, Ishikawa T, et al. Oncogenic osteomalacia presenting as bilateral stress fractures of the tibia. Skeletal Radiol. 1999;28:46-48.
64. Ohta H, Nakaishi S, Oki S, et al. Bone scintigraphy in a case of oncogenous osteomalacia. Clin Nucl Med. 1998;23:467-469.
65. Olefsky J, Kempson R, Jones H, et al. Tertiary hyperparathyroidism and apparent 'cure' of vitamin-D-resistant rickets after removal of an ossifying mesenchymal tumor of the pharynx. N Engl J Med. 1972;286:740-745.
66. Papotti M, Foschini MP, Isaia G, et al. Hypophosphatemic oncogenic osteomalacia: report of three new cases. Tumori. 1988;74:599-607.
67. Park JM, Woo YK, Kang MI, et al. Oncogenic osteomalacia associated with soft tissue chondromyxoid fibroma. Eur J Radiol. 2001;39:69-72.
68. Park YK, Unni KK, Beabout JW, et al. Oncogenic osteomalacia: a clinicopathologic study of 17 bone lesions. J Korean Med Sci. 1994;9:289-298.
69. Parker MS, Klein I, Haussler MR, et al. Tumor-induced osteomalacia: evidence of a surgically correctable alteration in vitamin D metabolism. JAMA. 1981;245:492-493.
70. Pollack JA, Schiller AL, Crawford JD. Rickets and myopathy cured by removal of a norrossifying fibroma of bone. Pediatrics. 1973;52:364-371.
71. Povysil C, Vlcek E. Could the Czech King Ladislav Pohrobek have had hypophosphatemic osteomalacia caused by a neoplastic disease? Cas Lek Cesk. 1992;131:339-341.
72. Prader A, Illig R, Uehlinger RE, et al. Rachitis infolge knochentumors [rickets caused by bone tumors]. Helv Pediatr Acta. 1959;14:554-565.
73. Prowse M, Brooks PM. Oncogenic hypophosphatemic osteomalacia associated with a giant cell tumour of a tendon sheath. Aust N Z J Med. 1987;17:330-332.
74. Rai GS. Oncogenic osteomalacia associated with metastatic prostate carcinoma [comment]. J Am Geriatr Soc. 1994;42:688.
75. Reese DM, Rosen PJ. Oncogenic osteomalacia associated with prostate cancer. J Urol. 1997;158:887.
76. Reid IR, Teitelbaum SL, Dusso A, et al. Hypercalcemic hyperparathyroidism complicating oncogenic osteomalacia: effect of successful tumor resection on mineral homeostasis. Am J Med. 1987;83:350-354.
77. Reis-Filho JS, Paiva ME, Lopes JM. Pathologic quiz case. A 36-year-old woman with muscle pain and weakness: phosphaturic mesenchymal tumor (mixed connective tissue variant)/oncogenic osteomalacia. Arch Pathol Lab Med. 2002;126:1245-1246.
78. Reyes-Mugica M, Amsmeier SL, Backeljauw PF, et al. Phosphaturic mesenchymal tumor-induced rickets. Pediatr Dev Pathol. 2000;3:61-69.
79. Rhee Y, Lee JD, Shin KH, et al. Oncogenic osteomalacia associated with mesenchymal tumour detected by indium-111 octreotide scintigraphy. Clin Endocrinol (Oxf). 2001;54:551-554.
80. Rico H, Fernandez-Miranda E, Sanz J, et al. Oncogenous osteomalacia: a new case secondary to a malignant tumor. Bone. 1986;7:325-329.
81. Rowe PS, de Zoysa PA, Dong R, et al. MEPE, a new gene expressed in bone marrow and tumors causing osteomalacia. Genomics. 2000;67:54-68.
82. Ryan EA, Reiss E. Oncogenous osteomalacia: review of the world literature of 42 cases and report of two new cases. Am J Med. 1984;77:501-512.
83. Ryan WG, Gitelis S, Charters JR. Studies in a patient with tumor-induced hypophosphatemic osteomalacia. Calcif Tissue Int. 1986;38:358-362.
84. Sakamoto A, Oda Y, Nagayoshi Y, et al. Glomangiopericytoma causing oncogenic osteomalacia: a case report with immunohistochemical analysis. Arch Orthop Trauma Surg. 2001;121:104-108.
85. Salassa RM, Jowsey J, Arnaud CD. Hypophosphatemic osteomalacia associated with 'neuroendocrine' tumors. N Engl J Med. 1970;282:65-70.
86. Sandhu FA, Martuza RL. Craniofacial hemangiopericytoma associated with oncogenic osteomalacia: case report. J Neurooncol. 2000;46:241-247.
87. Schapira D, Ben Izhak O, Nachtigal A, et al. Tumor-induced osteomalacia. Semin Arthritis Rheum. 1995;25:35-46.
88. Schultze G, Delling G, Faensen M, et al. Oncogenic hypophosphatemic osteomalacia. Dtsch Med Wochenschr. 1989;114:1073-1078.
89. Seufert J, Ebert K, Muller J, et al. Octreotide therapy for tumor-induced osteomalacia. N Engl J Med. 2001;345:1883-1888.
90. Shenker Y, Grekin RJ. Oncogenic osteomalacia. Isr J Med Sci. 1984;20:739-741.
91. Shimada I, Mizutani S, Muro I, et al. Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia. Proc Natl Acad Sci USA. 2001;98:6500-6505.
92. Siegel HJ, Rock MG. Occult phosphaturic mesenchymal tumor detected by Tc-99m sestamibi scan. Clin Nucl Med. 2002;27:608-609.
93. Siegel HJ, Rock MG, Inwards C, et al. Phosphaturic mesenchymal tumor. Orthopedics. 2002;25:1279-1281.
94. Sparagana M. Tumor-induced osteomalacia: long-term follow-up of two patients cured by removal of their tumors. J Surg Oncol. 1987;36:198-205.
95. Stone E, Bernier V, Rabinovich S, et al. Oncogenic osteomalacia associated with a mesenchymal chondrosarcoma. Clin Invest Med. 1984;7:179-185.
96. Stone MD, Quincey C, Hosking DJ. A neuroendocrine cause of oncogenic osteomalacia. J Pathol. 1992;167:181-185.
97. Sundaram M, McCarthy EF. Oncogenic osteomalacia. Skeletal Radiol. 2000;29:117-124.
98. Sweet RA, Males JL, Hamstra AJ, et al. Vitamin D metabolite levels in oncogenic osteomalacia. Ann Intern Med. 1980;93:279-280.
99. Taylor HC, Santa-Cruz D, Teitelbaum SL, et al. Assessment of calcitriol and inorganic phosphate therapy before cure of oncogenous osteomalacia by resection of a mixed mesenchymal tumor. Bone. 1988;9:37-43.
100. Tsujimura T, Sakaguchi K, Aozasa K. Phosphaturic mesenchymal tumor, mixed connective tissue variant (oncogenic osteomalacia). Pathol Int. 1996;46:238-241.
101. Uchida H, Yokoyama S, Kashima K, et al. Oncogenic vitamin D resistant hypophosphatemic osteomalacia (benign ossifying mesenchymal tumor of bone): case report. Jpn J Clin Oncol. 1991;21:218-226.
102. Weidner N, Bar RS, Weiss D, et al. Neoplastic pathology of oncogenic osteomalacia/rickets. Cancer. 1985;55:1691-1705.
103. Weidner N, Santa Cruz D. Phosphaturic mesenchymal tumors: a polymorphous group causing osteomalacia or rickets. Cancer. 1987;59:1442-1454.
104. Weiss D, Bar RS, Weidner N. Oncogenic osteomalacia. Ann Intern Med. 1985;102:557.
105. Weiss D, Bar RS, Weidner N, et al. Oncogenic osteomalacia: strange tumours in strange places. Postgrad Med J. 1985;61:349-355.
106. White KE, Waguespack SG, Econs MJ. Case 29-2001: oncogenic hypophosphatemic osteomalacia. N Engl J Med. 2002;346:381-382.
107. Wilkins GE, Granleese S, Hegele RG, et al. Oncogenic osteomalacia: evidence for a humoral phosphaturic factor. J Clin Endocrinol Metab. 1995;80:1628-1634.
108. Yamamoto T, Miyamoto KI, Ozono K, et al. Hypophosphatemic rickets accompanying McCune-Albright syndrome: evidence that a humoral factor causes hypophosphatemia. J Bone Miner Metab. 2001;19:287-295.
109. Yang IM, Park YK, Hyun YJ, et al. Oncogenic osteomalacia caused by a phosphaturic mesenchymal tumor of the oral cavity: a case report. Korean J Intern Med. 1997;12:89-95.
110. Yoshikawa S, Nakamura T, Takagi M, et al. Benign osteoblastoma as a cause of osteomalacia: a report of two cases. J Bone Joint Surg Br. 1977;59:279-286.
111. Yu GH, Katz RL, Raymond AK, et al. Oncogenous osteomalacia: fine needle aspiration of a neoplasm with a unique endocrinologic presentation. Acta Cytol. 1995;39:831-832.
112. Zura RD, Minasi JS, Kahler DM. Tumor-induced osteomalacia and symptomatic looser zones secondary to mesenchymal chondrosarcoma. J Surg Oncol. 1999;71:58-62.